THE WISKOTT-ALDRICH SYNDROME PROTEIN (WASP): Roles in Signaling and Cytoskeletal Organization
- 1 April 1999
- journal article
- review article
- Published by Annual Reviews in Annual Review of Immunology
- Vol. 17 (1) , 905-929
- https://doi.org/10.1146/annurev.immunol.17.1.905
Abstract
The Wiskott-Aldrich Syndrome (WAS) is a rare X-linked primary immunodeficiency that is characterized by recurrent infections, hematopoietic malignancies, eczema, and thrombocytopenia. A variety of hematopoietic cells are affected by the genetic defect, including lymphocytes, neutrophils, monocytes, and platelets. Early studies noted both signaling and cytoskeletal abnormalities in lymphocytes from WAS patients. Following the identification of WASP, the gene mutated in patients with this syndrome, and the more generally expressed WASP homologue N-WASP, studies have demonstrated that WASP-family molecules associate with numerous signaling molecules known to alter the actin cytoskeleton. WASP/N-WASP may depolymerize actin directly and/or serve as an adaptor or scaffold for these signaling molecules in a complex cascade that regulates the cytoskeleton.Keywords
This publication has 173 references indexed in Scilit:
- Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndromeThe Journal of Pathology, 1998
- Direct Binding of the Verprolin-Homology Domain in N-WASP to Actin Is Essential for Cytoskeletal ReorganizationBiochemical and Biophysical Research Communications, 1998
- Identification of WASP mutations, mutation hotspots and genotype-phenotype disparities in 24 patients with the Wiskott-Aldrich syndromeHuman Genetics, 1996
- Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein geneThe Journal of Pediatrics, 1996
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995
- A multiinstitutional survey of the Wiskott-Aldrich syndromeThe Journal of Pediatrics, 1994
- Splenectomy in the Management of the Thrombocytopenia of the Wiskott–Aldrich SyndromeNew England Journal of Medicine, 1980
- Complete Correction of the Wiskott-Aldrich Syndrome by Allogeneic Bone-Marrow TransplantationNew England Journal of Medicine, 1978
- Attenuated form of Wiskott-Aldrich syndromeThe Journal of Pediatrics, 1973
- Platelet survival in Wiskott-Aldrich syndromeThe Journal of Pediatrics, 1966